by Biolexis | Feb 23, 2023 | News & Media
February 22-23, 2023 Biolexis Therapeutics Business Development team participated 2nd Next Generation Kinase Inhibitors Summit was held on February 22-23, 2023, in Boston.
by Biolexis | Nov 14, 2022 | News & Media
November 14-15, 2022 Biolexis Therapeutics Management participates and presents their MolecuLern technology at Precision in Drug Discovery & Preclinical Summit 2022 on Nov 14-15, 2022, San Francisco CA, US.
by Biolexis | Oct 27, 2022 | News & Media
Oct 27-28, 2023 Biolexis Therapeutics Management participates and presents their MolecuLern technology at 10th Drug Discovery Strategic Summit, Oct 27th – 28th 2022, San Francisco CA, US
by Biolexis | Sep 27, 2022 | News & Media
September 21-22, 2022 Biolexis Therapeutics Business Development Director Kyle Medley participated in RESI Conference (Redefining Early-Stage Investments), Boston, MA on Sep 21-22, 2022. https://resiconference.com/
by Biolexis | Apr 13, 2022 | News & Media
April 8-13, 2022 BioLexis is pleased to announce the acceptance of a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting, taking place at the Ernest N. Morial Convention Center in New Orleans from April 8-13, 2022. Representing...